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The marked increase in the number of circulating lymphocytes induced in 
experimental animals by the lymphocytosis-promoting  factor (LPF) ~ of phase I 
Bordetella pertussis is due to redistribution of cells from lymphoid tissues into 
the blood (1-4). The redistribution involves in large part the failure of recirculat- 
ing lymphocytes to "home" into lymph nodes at a normal rate (5, 6). However, 
the mechanism responsible for failure of normal homing is unknown. In addi- 
tion, although LPF binds to a variety of cells, including lymphocytes (7), little is 
known of the consequences of this interaction. Parker and Morse (8) did find, 
however, that fractions of culture supernates of B. pertussis  rich in LPF in- 
hibited the accumulation of cyclic adenosine 3',5'-monophosphate (cAMP)  in 
human lymphocytes which is normally induced by isoproterenol and prostaglan- 
din El. 
Recently, procedures have been developed in this laboratory for the isolation 
of LPF (9) which was found to be a protein which not only causes lymphocytosis 
but also sensitizes mice to histamine and,  in addition,  produces a  markedly 
diminished hyperglycemic  response to epinephrine. 
The availability of highly purified preparations has made it possible to pursue 
studies  on  the  in  vitro  effects of LPF.  In  the  studies  reported herein,  the 
interaction between  LPF  and  cultured murine lymphocytes was  examined. 
Surprisingly, LPF proved to be a potent lymphocyte mitogen in vitro, despite 
the fact that pertussis-induced lymphocytosis is not accompanied by lymphocyte 
proliferation (1). A preliminary account of these findings has been presented 
previously (10). 
Materials and Methods 
Animals.  Inbred female CBA/J (CBA) mice, 8-to-12 wk of age, were employed for most of the 
experiments  and  were  obtained  from  The  Jackson  Laboratory,  Bar  Harbor,  Maine,  or  from 
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S. Public Health Service. Portions of this work were submitted by A. S. K. in partial fulfillment of 
the  requirements  for the  Ph.D.  degree  in  the  Department of Microbiology  and  Immunology, 
Downstate Medical Center. 
1Abbreviations  used  in  this paper:  Con  A,  concanavalin A;  LPF,  lymphocytosis-promoting 
factor; LPS, lipopolysaccharide; PHA, phytohemagglutinin. 
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Jackson stock bred in this department. C57BL/6J (C57), BALB/cJ (BALB), C3H/HeJ (C3H) inbred 
animals were also obtained from The Jackson Laboratory, while outbred Albany mice were from 
the Griffin Laboratory, Albany, N. Y. Conventional and germ-free CD-1 animals were purchased 
from Charles River Mouse Farm Inc., Wilmington, Mass. 
LPF.  LPF was isolated from culture supernatant fluids of phase I B. pertussis strain NIH 114 
by previously described methods (2). Intravenous injection of 0.5 pg of LPF protein into CD-1 mice 
resulted  in  a  leukocytosis  of  110,000-160,000  cells/mm  3 3  days  later,  and  small  lymphocytes 
comprised 60-70% of the population. 
Mitogens.  Phytohemagglutinin-M (PHA-M) was obtained from Difco Laboratories,  Detroit, 
Mich., and after reconstitution was stored in aliquots at -20°C. PHA-P (Difco Laboratories) was 
used in some experiments with qualitatively identical results.  Con A  was obtained from Calbi- 
ochem, San Diego,  Calif. LPS,  isolated from Salmonella typhosa  by the phenol-water technique 
(11),  was kindly supplied by Dr.  B. M. Sultzer of this Department. 
Cell Cultures.  The medium used throughout, unless other specified, was RPMI 1640  (Grand 
Island  Biological  Co.,  Grand Island,  N.  Y.)  supplemented with 5%  heat-inactivated fetal  calf 
serum (FCS) (Reheis Chemical Co., Phoenix, Ariz.), penicillin (100 U/ml), and streptomycin (100 
~g/ml).  Mice were killed by cervical dislocation, and isolated cells were prepared from spleen, 
inguinal, and axillary lymph nodes, and thymus by teasing the organs with forceps into medium. 
Tissue fragments were allowed to sediment spontaneously, and the supernate containing single 
cells was aspirated. 
In some experiments suspensions of bone marrow cells were employed.  These were prepared 
from femora that were freed from adhering muscle and fascia. The ends of the bones were cut with 
scissors and the marrow plug expelled with a  26-gauge needle. The cells were dispersed with a 
Pasteur pipette. 
Cell suspensions were centrifuged, washed once, and resuspended in fresh medium. Viability 
was assessed with the trypan blue dye exclusion test, and only preparations with greater than 90% 
cell viability were utilized. 
Cell Cultures.  In most experiments the cell suspensions were adjusted to 4  ×  10  e viable cells/ 
ml and mixed with an equal volume of medium containing mitogen, or the solvent used for the 
mitogen. Then 0.25 ml of the mixture, containing 0.5 x  10  ~ cells, was added to wells of flat bottom 
microtiter  plates  (Model  IS  FB-96-TC,  Linbro  Chemical  Co.,  New  Haven,  Conn).  Triplicate 
cultures were incubated at 37°C in a  humid atmosphere of 5% CO2 in air for the indicated time 
periods. 
Determination  of DNA Synthesis.  8 h before harvest, 2.0 ~tCi of [~H]thymidine, sp act 6.0 Ci/ 
mM  (Schwarz/Mann,  Orangeburg,  N.  Y.),  was  added to the cultures in a  vol  of 0.02  ml.  The 
cultures were harvested on glass fiber filter papers (grade 934 AH, Reeve Angel, Clifton, N. J.) 
with an automated sampler (Otto Hiller Co., Madison, Wisc.) and the filters washed with saline. 
The dried filters were placed in 5 ml of an Omnifluor-toluene scintillation mixture (New England 
Nuclear,  Boston,  Mass.)  and  counted.  The  responses  are  presented  as  mean  cpm  -+  1  SD  of 
triplicate samples  less background and occasionally as the stimulation index  (SI) where  SI  = 
(mean cpm of stimulated cultures)/(mean cpm of control cultures). 
Light Microscopy.  Morphological examination of cultured cells for evidence of transformation 
was  performed  on  Wright-Giemsa  stained  preparations  which  had  been  sedimented  with  a 
Shandon Cytocentrifuge (Rainen Instruments Co., Fort Lee, N. J.). 
Results 
Effect of Various Concentrations of LPF on the Proliferation of CBA Lymph 
Node  and  Spleen  Cells.  Various  quantities of LPF were  added to  cultures 
containing 0.5 × 106 CBA lymph node or spleen cells in a final vol of  0.25 ml, and 
the incorporation of [3H]thymidine at 72 h was determined. This time period was 
selected on the basis of results obtained in preliminary experiments. As can be 
seen in Fig. 1, there was a relatively sharp optimum dose of 0.5  ~g of LPF per 
culture for lymph node cells, while the optimum dose for spleen cells was 0.25- 
0.5 ~g. However, the overall response of lymph node cells was slightly less dose 
dependent,  good stimulation being  seen  at doses  of 0.25-0.75  ~g.  At higher AH  SWEE  KONG  AND  STEPHEN  I.  MORSE 
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FIG.  1.  The incorporation of [3H]thymidine by CBA lymph node cells (0-  0) and spleen 
cells (m- m) in response to various quantities of LPF.  Cultures contained 0.5 ×  10  e cells in 
0.25 ml,  and results are shown as the mean cpm  ×  10  -3 minus background after 72 h  of 
incubation. 
concentrations of LPF there was  marked suppression of the proliferative re- 
sponse (Fig.  1),  but viability studies indicated that the suppression was not a 
manifestation of cytotoxicity of LPF. 
Time-Course of the Proliferative Response to LPF.  As shown in Fig. 2, when 
CBA spleen cells were incubated with optimum doses of  0.25 or 0.5 ~g of LPF per 
culture,  virtually no  proliferative response  could be  detected at  24  h.  Peak 
incorporation of [3H]thymidine was found at 72 h, while at 96 h  incorporation 
was markedly diminished. 
Morphologic findings paralleled the results of estimation of proliferation by 
[3H]thymidine incorporation. After 72 h of incubation of spleen cells with 0.5 ~g 
of LPF, 70-90%  of the cells were blast forms and mitotic figures were frequent 
(Fig. 3). 
In the case of lymph node cells (Fig. 2), the response to the optimum dose of  0.5 
~g of LPF was maximal at 72 h, whereas for the higher dose of 0.75 ~g the peak 
was usually at 48 h. In the presence of 0.25  ~g of LPF the response increased 
successively over 96 h  although not in a  strictly linear fashion. 
Comparison of the Mitogenic Effects of  LPF, PHA, and Concanavalin A  (Con 
A) on CBA Spleen Cells.  The comparative ability of optimum amounts of LPF, 
PHA, and Con A to stimulate 0.5  × 10  ~ CBA spleen cells was tested at 48 and 72 20C 
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FIo.  2.  [3H]thymidine  incorporation  at  various  time  periods  by  CBA  spleen  cells  in 
response to 0.25 ~g (A-  A) and 0.5 ~g (@-0)  of LPF per culture (left), and by CBA lymph 
node cells to 0.25, 0.5, and 0.75 ~g (m -  m) of LPF (right). Cultures contained 0.5 x  10  e cells 
in 0.25 ml. Results are expressed as mean cpm x  10  -3 minus background. 
h  of culture.  Under these conditions it was found that LPF was much more 
potent than PHA, but somewhat less than Con A (Table I). 
Effect of Cell Concentration on the Response to LPF.  It is well known that 
the concentration of lymphocytes markedly affects the extent of proliferation in 
mixed lymphocyte cultures (12) as well as reactivity to the phytomitogen PHA 
(13). Therefore, the response of differing numbers of CBA spleen cells in 0.25 ml 
to 0.5  ~g of LPF, a dose optimum for 0.5  x  106 cells, was examined. As can be 
seen in Table II, 0.25  x  l0  s cells showed little response to this amount of LPF, 
whereas  there  was  marked  response  at  higher  cell  concentrations  without 
significant differences in the extent of [3H]thymidine incorporation. This result 
stood in marked contrast to the decreased reactivity of the highest cell concen- 
tration, 2.0  x  108/0.25 ml, to PHA (Table II). 
Evidence  that  LPF  is  a  Nonspecific  Mitogen.  A  critical  question  was 
whether the response to LPF represents an in vitro manifestation of antigen 
stimulation of cells presensitized either to LPF or to antigens cross-reactive with 
it, or whether LPF is a  nonspecific, polyclonal mitogen. Two types of experi- 
ments suggested that presensitized cells were not responsible for the reaction. 
Firstly, as shown in Table III, spleen cells from a  variety of mouse strains 
were reactive. Secondly, with respect to both LPF and PHA, spleen cells from 
individual axenic CD-1 mice showed the same range of reactivity as did spleen 
cells from conventionally reared CD-animals (Table IV). 
Effect of LPF on Thymocytes from Normal and Cortisone-Treated Mice.  For 
these experiments BALB mice were employed since their thymocytes tend to be 
more reactive to mitogens than those of other strains. Yet as shown in Fig. 4, 0.5 
x  106 BALB thymocytes did not respond to a wide range of LPF concentrations, AH  SWEE  KONG  AND  STEPHEN  I.  MORSE  155 
FIG. 3.  Morphology of CBA spleen cells, 0.5 x  l0  s cells/0.25 ml, after 72 h of incubation 
with 0.5 #g of LPF.  Wright-Giemsa x  1250. 
TABLE I 
[3H]thymidine Incorporation by CBA Spleen Cells in Response to Mitogens 
Mitogen  Dose 
[3H]thymidine  incorporation 
48 h  72 h 
LPF  0.5 ~tg  88,926 +_ 4,718"  150,069 _+ 10,655 
PHA 
Con A 
1.25/~1  31,356 _+ 1,147  62,713 _  2,843 
2.5/~l  37,949 _+ 3,726  52,267 _  2,228 
3.75/~1  33,318 -+ 4,774  57,894 _+ 3,434 
0.25 /~g  112,994 _+ 4,398  170,238 _+ 2,446 
0.5/~g  138,309 _+ 2,570  180,357 _+ 6,077 
0.75/~g  120,033 _+ 3,619  172,438 +__ 2,960 
None  -  2,244 _+ 71  1,597 -+ 180 
* Mean cpm _  SD of triplicate cultures. 
whereas  they  did  respond  to  Con  A.  However,  when  the  concentration  of 
thymocytes  was  increased  to  1.0-2.0  ×  l0  s  cells/0.25  ml,  slight  but  definite 
proliferation occurred  (Table V).  Since it has been shown that while the vast 
majority of thymocytes  do  not  respond to  PHA,  there  exists  a  population of 156  MURINE  LYMPHOCYTE  RESPONSE  TO  LPF°I 
TASLE  II 
[3H]thymidine Incorporation by Varying Numbers of CBA Spleen Cells in Response to 
LPF and PHA 
Number of cells per culture 
Mitogen 
0.25  x  l0  s  0.5  ×  10  ~  1.0  ×  108  2.0  ×  10  ~ 
None  933  -+  112"  2,252  _+  394  7,901  -+ 1,260  18,176  -+ 1,771 
LPF (0.5  ~g)  24,751  +_  1,553  173,389  ±  4,731  198,715  ±  2,014  171,778  ... 7,016 
PHA (2.5 ~1)  26,857  ±  6,806  81,302  _  2,300  115,564  _+  14,152  42,258  _+  12,695 
* Mean cpm ±  SD of triplicate cultures at 72 h. 
TABLS  III 
[3H]thymidine Incorporation  by Spleen Cells from Different 
Mouse Strains in Response to LPF 
Mouse strain  Medium alone  LPF (0.5  ~g)  SI* 
CBA/J  1,597  ±  1805  150,069  ±  10,665  93.9 
C57BL/6J  471  ...  124  119,601 -  2,424  253.9 
BALB/cJ  1,461  ±  477  92,257  _+ 4,348  63.1 
DBA/2J  2,600  _+  646  78,469  +- 2,328  30.1 
C3H/HeJ  986  _+  214  78,879  ±  8,344  79.9 
CD-1  2,221  ±  706  150,840  -+  15,248  67.9 
Albany  1,965  ±  375  101,090 ±  7,009  51.4 
* Stimulation index. 
$ Mean cpm -+ SD of triplicate cultures at 72 h~ 
TABLE  IV 
[ZH]thymidine Incorporation by Spleen Cells from Individual Normal and Axenic CD-1 
Mice in Response to LPF and PHA 
Mitogen added 
None  LPF (0.25  ~g)  LPF (0.5  ~g)  PHA (2.5  ~l) 
Axenic CD-1  528  ±  109"  11,817  ±  727  53,053  +_  11,463  58,055  +_  13,044 
2,458  +_  820  107,572  -+  18,642  157,943  ±  11,342  69,468  _  8,479 
1,566  ±  110  78,110  ±  12,991  108,404  ±  12,318  53,145  ±  8,128 
2,200  -  132  39,130  +_  12,247  114,964  ±  1,791  57,558  ... 5,377 
2,059  _+ 864  53,391  ±  10,811  132,171  +_ 8,432  58,193  +_  31,955 
Normal CD-1  2,221  ±  706  56,198  +_  11,348  150,840  ±  15,248  120,718  +_ 9,846 
454  _+ 60  11,418  ±  2,316  40,838  +  14,783  22,112  ±  3,286 
1,349 ±  207  54,934  -  15,474  171,406  4- 6,561  80,650  _+  4,606 
* Mean cpm ±  1 SD of triplicate cultures harvested at 72 h. 
cortisone-resistant thymocytes which are stimulated by this mitogen (14), it was 
important to determine whether the same was true with respect to LPF. 
It can be seen in Table VI that, as in the case of PHA, 30 h after injection of 5 
mg of cortisone acetate there was a residual population of steroid-resistant cells 
which responded to LPF. 
Effect of LPF on Bone Marrow Cells.  Fig. 5 illustrates that whereas CBA 
bone marrow cells incorporated [3H]thymidine when incubated for 72 h  with 
LPS, there was no response to several concentrations of LPF. AH  SWEE  KONG  AND  STEPHEN  I.  MORSE  157 
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FIa. 4.  [SH]thymidine incorporation  by BALB thymocytes 0.5 × l0  s cells/culture after 72 h 
of incubation with Con A (,-  m) or LPF (O-O). 
TABLE V 
[3H]thymidine Incorporation by Varying Numbers of  BALB Thymus Cells in Response 
to LPF and Con A 
Number of cells per culture 
Mitogen 
0.25 × 106  0.5 × 10  ~  1.0 x  l0  s  2.0 + 106 
None  43 _+ 5*  76 -+ 11  117 _+ 5  150 _+ 14 
LPF (0.5 ~g)  169 __. 6  437 _+ 53  1,324 +_ 134  3,948 _+ 811 
Con A (0.5 ~g)  3,710 +_ 270  28,000  +_ 4,135  114,949  _+ 17,194  183,242  _+ 26,554 
* Mean cpm _+ SD of triplicate cultures at 48 h. 
Abrogation of the Proliferative Response by LPF Antiserum.  Monospecific 
LPF antiserum was prepared in rabbits as described previously (9). When added 
at the initiation of the in vitro cultures, it was found that as little as 150 nl of 
antiserum  specifically  nullified the  proliferative  response  to  LPF,  whereas 
normal  rabbit  serum  had  no  effect.  Moreover,  the  LPF  antiserum  affected 
neither background counts nor PHA reactivity. 
This reagent proved useful in assessing the duration of contact between cells 158  MURINE  LYMPHOCYTE  RESPONSE  TO  LPF-I 
TABLE  VI 
Mitogen Response  of Thymocytes from Normal and Cortisone Acetate-Treated  BALB 
Mice 
Mitogen 
Treatment 
LPF (0.5 tLg)  LPF (0.75 ttg)  PHA (2.5 #l)  Con A (1 tLg)  None 
None  261  _+ 48*  360 _+ 50  497  +  20  18,700 _+ 7,577  65 _+ 12 
Cortisone  25,826 _+ 510  37,203  +_ 3,569  35,337 _+ 4,229  198,795  _+ 8,081  933  _~ 19 
* Mean cpm _+ SD at 48 h. 
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Fro.  5.  [3H]thymidine incorporation by 0.5 x  106 CBA bone marrow cells after incubation 
for 72 h with either LPF or LPS. 
and LPF which was required to initiate a  proliferative reaction. Antiserum  (625 
nl) was added at various times, and the incorporation of [3H]thymidine by CBA 
spleen cells at 72 h  was compared to that in cultures containing 625 nl of normal 
rabbit serum. 
As seen  in  Fig.  6,  complete  abrogation  of the  response  occurred  when  anti- 
LPF  was added up to 3  h  after cultures were initiated. There was successively 
less inhibition when antiserum  was added at 12 and at 24 h, but even at 48 h  the 
introduction of antiserum  resulted in a  40% reduction in [3H]thymidine incorpo- 
ration at 72 h. Normal rabbit serum had no inhibiting effect, and LPF antiserum 
did not affect the response to PHA. 
These  results  were  supported by other experiments  in  which the  cells were 
washed  free of LPF at various time periods and resuspended  in fresh medium. 
Although the data are not strictly comparable owing to differences in design and 
the  difficulty  in  washing  out  cell-bound  LPF,  it  was  found  that  removal  of 
extracellular  LPF  as late as 24 h  resulted in a  decreased response at 72 h. 
The anti-LPF  serum also proved useful in assessing whether  LPF induced the AH  SWEE  KONG  AND  STEPHEN  T.  MORSE  159 
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FIG. 6.  The effect of  the addition of  625 nl of  rabbit LPF antiserum (@- @) at various time 
periods on the incorporation of [3H]thymidine by cultures of  CBA spleen cells containing 0.5 
~g of LPF. In control cultures normal rabbit serum (,) was added at the initiation of the 
cultures. The data are expressed as mean cpm x 10  -3, minus background, after a total of 72 
h in culture. 
production ofa mitogenic factor from stimulated lymphocytes. CBA spleen cells 
were incubated with LPF for various time periods. The cells were then removed 
by centrifugation, and the supernatant fluids, to which LPF antiserum had been 
added, were used in fresh spleen cell cultures. No mitogenic effect was found. 
Discussion 
Previous studies have clearly shown that the lymphocytosis induced by LPF 
in experimental animals is due to redistribution of cells and is not the result of 
lymphocyte proliferation (1-6). Yet, in the in vitro studies reported herein, LPF 
was found to be a  potent mitogen for cultured murine lymphocytes. 
It is unlikely that the mitogenic principle of phase I B. pertussis is a contami- 
nant present in LPF preparation. In unpublished experiments, not only was the 
total LPF fraction mitogenic, but so was the eluate from the major band found 
when  undissociated  LPF is  subjected  to  polyacrylamide electrophoresis.  The 
same eluate, as previously shown (9), induced lymphocytosis, histamine sensiti- 
zation, and epinephrine unresponsiveness in mice. Further confirmation that an 160  MURINE  LYMPHOCYTE  RESPONSE  TO  LPF-I 
identical  substance causes the in vivo and in vitro effects is derived from the 
finding that a monospecific LPF antiserum abrogated the diverse reactions. 
The most likely explanation for the discrepancy between the in vivo and in 
vitro effects lies in the different dose of LPF required for in vitro stimulation 
compared with that which induces lymphoc~¢osis. Optimum lymphocytosis in 
mice is caused by the injection of 0.5-1.0 ~g of LPF, whereas there is a  sharp 
optimum of approximately 0.5/zg required for the in vitro proliferation of 0.5 × 
108 lymphocytes; markedly diminished responses occur when less than 0.25 ~g is 
used. Thus, the dilution of LPF in the plasma volume alone accounts for the lack 
of DNA replication in the lymphocytes of intact mice. Moreover, while there is 
no information on the distribution of LPF in cellular and extracellular compart- 
ments, it is known that LPF reversibly attaches to a variety of mammalian cells 
(7)  which  would  further  reduce  the  effective concentration  available  to  the 
lymphocytes. Although it is possible that exceedingly large doses of LPF might 
produce lymphocyte proliferation in vivo, it is obvious that proliferation is not 
mandatory  for lymphocytosis. In this  regard  it is of interest  that  while  LPF 
induces lymphocytosis in nude mice (9), LPF does not cause in vitro stimulation 
of either spleen cells or lymph node cells from these animals  (15). 
Although there is no known animal reservoir of B. pertussis,  it was possible 
that sensitization of lymphocytes to bacterial antigens cross-reacting with LPF 
could have occurred, and that the mitogenic response to LPF was due to specific 
antigen stimulation.  This possibility was rendered unlikely by the finding that 
spleen cells from germ-free mice responded as well to LPF as did spleen cells 
from conventionally reared mice of the same strain. A variety of bacteriological 
procedures were employed to ensure that the axenic mice were indeed free of 
culturable microorganisms.  It might still be argued that the mice were sensi- 
tized to cross-reactive viral  or food antigens.  This  idea seems untenable  for 
several reasons.  Spleen  cells from a  number  of mouse strains  obtained from 
several sources responded to approximately the same extent. In addition, sero- 
logical tests did not reveal evidence of exposure to LPF or cross-reactive anti- 
gens. The magnitude of the proliferative response, which exceeds that produced 
by PHA and is only slightly less than that seen with Con A, is also far greater 
than that generally observed with antigen-sensitized mouse lymphoid cells. The 
results  of experiments  performed  with human  lymphocytes also  support the 
thesis that LPF is a  nonspecific mitogen (J. H. Morse, A. S.  Kong, J. Linden- 
baum, and S. I. Morse, unpublished observations). 
The  availability of specific LPF antiserum,  which blocks the mitogenic re- 
sponse, permitted analysis of the time-dependent requirement for serologicaUy 
active LPF in the lymphocyte cultures.  A minimum period of several hours of 
exposure to LPF, in the absence of antiserum,  was required for any response to 
occur. It was striking that when LPF antiserum,  but not normal rabbit serum, 
was added as late as 48 h, subsequent diminution of [~Hlthymidine incorpora- 
tion occurred. The data do not allow one to determine whether this was due to 
neutralization  of extracellular  LPF or to the  consequences  of an  interaction 
between the antiserum and LPF which might be cell-bound. 
B. pertussis  is a  gram-negative organism which contains lipopolysaccharide 
endotoxin  (LPS),  but  a  number  of experiments  indicated  that  the  observed 
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Chemical analysis of LPF reveals no lipid (9)  and, furthermore, LPF did not 
cause cultured bone marrow cells to incorporate [3H]thymidine, whereas LPS 
from S. typhosa did. LPS prepared from the homologous strain ofB. pertussis by 
the phenol-water technique (11), unlike LPF, also stimulated bone marrow cells 
(unpublished observations). 
Spleen cells and lymph node cells were responsive to LPF, but normal thymo- 
cytes were not stimulated by LPF except at high cell concentrations. However, 
there existed a cortisone-resistant population of thymocytes which was respon- 
sive to LPF. In contrast to LPF, Con A-stimulated normal thymocytes, whereas 
PHA, like LPF, stimulated only cortisone-resistant thymus cells. 
In an accompanying paper it will be shown that the lymphocytes stimulated 
by LPF are T cells sensitive to Thy-1 antiserum, which comprise a  population 
different from those that react to PHA. Moreover, adherent, Thy-1 insensitive 
cells were found to be required for initiation of the response. 
Summary 
The lymphocytosis-promoting  factor ofBordetella pertussis is a  potent mito- 
gen for murine tymphocytes in  vitro.  The stimulatory response  was not the 
result of specific antigen stimulation. Spleen and lymph node cells were respon- 
sive, whereas normal thymocytes were unresponsive. However, DNA replica- 
tion was induced in cortisone-resistant thymocytes by lymphocytosis-promoting 
factor (LPF). Bone marrow cells were not stimulated by LPF. 
We are indebted to Mrs. Carol D. Stearns and Mrs. Susan R. Goldsmith for expert technical 
assistance. 
Received for publication 15 September 1976. 
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